Table 1 Demographic and clinical characteristics
|  | Without insomnia disorders (N = 6290; 70%) | With insomnia disorders (N = 2664; 30%) | P-value |
|---|---|---|---|
Age in years, Wmean (SD) | 39 (16) | 45 (17) |  < 10–4 |
Gender (women), N (%) | 2921 (46) | 1411 (53) |  < 10−3 |
Smokers (yes), N (%) | 2976 (53) | 1350 (55) | 0.06 |
Psychiatric diagnosis a N (%): |  |  |  < 10–3 |
  Others | 743 (17) | 324 (16) |  |
  Psychotic disorders | 1641 (37) | 625 (31) |  |
  Schizoaffective disorders | 359 (8) | 264 (13) |  |
  Bipolar disorders | 753 (17) | 390 (20) |  |
  Depression | 934 (21) | 399 (20) |  |
Risk of weight gain for psychotropic drugs b, N (%): |  |  |  < 10–3 |
  Low risk | 1307 (21) | 457 (17) |  |
  Medium risk | 3751 (59) | 1569 (59) |  |
  High risk | 1230 (20) | 638 (24) |  |
BMI kg/m2, Wmean (SD) | 25.5 (5.4) | 25.9 (5.7) | 0.001 |
WC cm, Wmean (SD) | 91 (15) | 93 (16) |  < 10–4 |
BP mmHG, Wmean (SD): | |||
  Systolic | 122 (16) | 122 (16) | 0.82 |
  Diastolic | 79 (12) | 79 (12) | 0.56 |
FPG mmol/L, Wmean (SD) | 5.03 (1.15) | 5.22 (1.32) |  < 10–4 |
Plasma cholesterol, mmol/L, Wmean (SD): | |||
  HDL | 1.36 (0.41) | 1.37 (0.43) | 0.47 |
  LDL | 2.80 (0.93) | 2.86 (0.93) | 0.08 |
  Triglycerides | 1.44 (1.00) | 1.41 (0.88) | 0.31 |
  Total | 4.83 (1.10) | 4.87 (1.11) | 0.23 |